126 related articles for article (PubMed ID: 7127838)
21. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Gastroenterology; 1983 Aug; 85(2):254-9. PubMed ID: 6602726
[TBL] [Abstract][Full Text] [Related]
22. Serum and urinary aminoterminal type III procollagen peptide in progressive systemic sclerosis: relationship to sclerodermal involvement, serum hyaluronan and urinary collagen metabolites.
Hørslev-Petersen K; Ammitzbøll T; Engström-Laurent A; Bentsen K; Junker P; Asboe-Hansen G; Lorenzen I
J Rheumatol; 1988 Mar; 15(3):460-7. PubMed ID: 3259985
[TBL] [Abstract][Full Text] [Related]
23. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
Arrago JP; Poirier O; Najean Y
Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
[TBL] [Abstract][Full Text] [Related]
24. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma.
Tomás C; Risteli J; Risteli L; Vuori J; Kauppila A
Obstet Gynecol; 1991 Apr; 77(4):566-72. PubMed ID: 2002979
[TBL] [Abstract][Full Text] [Related]
25. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology.
Jensen LT
Dan Med Bull; 1997 Feb; 44(1):70-8. PubMed ID: 9062765
[TBL] [Abstract][Full Text] [Related]
26. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.
Linkhart SG; Linkhart TA; Taylor AK; Wergedal JE; Bettica P; Baylink DJ
Clin Chem; 1993 Nov; 39(11 Pt 1):2254-8. PubMed ID: 8222218
[TBL] [Abstract][Full Text] [Related]
27. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
28. Serum aminoterminal propeptide of type III procollagen in systemic sclerosis. A follow-up--investigations in subclasses and during therapy.
Heickendorff L; Parvez A; Bjerring P; Halkier-Sørensen L; Zachariae H
Acta Derm Venereol; 1991; 71(3):185-8. PubMed ID: 1678217
[TBL] [Abstract][Full Text] [Related]
29. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
Bolarin M
J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
[TBL] [Abstract][Full Text] [Related]
30. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
[TBL] [Abstract][Full Text] [Related]
31. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
[TBL] [Abstract][Full Text] [Related]
32. The aminoterminal-type-III procollagen peptide and proteoglycans in serum and synovial fluid of patients with rheumatoid arthritis or reactive arthritis.
Hørslev-Petersen K; Saxne T; Haar D; Thomsen BS; Bentsen KD; Junker P; Lorenzen I
Rheumatol Int; 1988; 8(1):1-9. PubMed ID: 3259005
[TBL] [Abstract][Full Text] [Related]
33. Primary fibromyalgia: clinical parameters in relation to serum procollagen type III aminoterminal peptide.
Jacobsen S; Jensen LT; Foldager M; Danneskiold-Samsøe B
Br J Rheumatol; 1990 Jun; 29(3):174-7. PubMed ID: 2357497
[TBL] [Abstract][Full Text] [Related]
34. Type I and III procollagen propeptides in growth hormone-deficient patients: effects of increasing doses of GH.
Jensen LT; Jørgensen JO; Risteli J; Christiansen JS; Lorenzen I
Acta Endocrinol (Copenh); 1991 Mar; 124(3):278-82. PubMed ID: 2011916
[TBL] [Abstract][Full Text] [Related]
35. Macrophage colony-stimulating factor 1, a clinically useful tumor marker in endometrial adenocarcinoma: comparison with CA 125 and the aminoterminal propeptide of type III procollagen.
Hakala A; Kacinski BM; Stanley ER; Kohorn EI; Puistola U; Risteli J; Risteli L; Tomás C; Kauppila A
Am J Obstet Gynecol; 1995 Jul; 173(1):112-9. PubMed ID: 7631667
[TBL] [Abstract][Full Text] [Related]
36. Structure of antigenic determinants in the N-terminal region of dermatosparactic sheep procollagen type I.
Rohde H; Timpl R
Biochem J; 1979 Jun; 179(3):643-7. PubMed ID: 89844
[TBL] [Abstract][Full Text] [Related]
37. Radioimmunoassay for the amino-terminal sequences of type III procollagen in human body fluids measuring fragmented precursor sequences.
Pierard D; Nusgens BV; Lapiere CM
Anal Biochem; 1984 Aug; 141(1):127-36. PubMed ID: 6496923
[TBL] [Abstract][Full Text] [Related]
38. Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
Risteli L; Risteli J; Puistola U; Tomás C; Zhu GG; Kauppila A
Acta Obstet Gynecol Scand Suppl; 1992; 155():99-103. PubMed ID: 1502898
[TBL] [Abstract][Full Text] [Related]
39. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
40. Aminoterminal propeptide of type III procollagen in healing wound in humans.
Haukipuro K; Risteli L; Kairaluoma MI; Risteli J
Ann Surg; 1987 Dec; 206(6):752-6. PubMed ID: 3689011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]